Purgo Labs
$69.99- Price / mg
- $0.07
- Document access
- Public link
Live UPS rate; free UPS 3 Day Select over $250
Four like-for-like public US 1000 mg NAD+ research-material listings, with single-vial price, nominal unit cost, availability, evidence access, and checked date kept together.
Current answer. As of Jul 23, 2026, 3 confirmed in-stock listings run from $69.99 to $129.79, with a $125.00 median across the in-stock rows. All 4 seller pages remain visible below.
Live UPS rate; free UPS 3 Day Select over $250
$9.95 US; free over $150
A list-price starting point, not a product-quality, safety, or seller recommendation.

List price, document access, and final landed cost answer different questions. This view keeps them separate instead of turning them into one seller score.
Live UPS rate; free UPS 3 Day Select over $250
Open vendor evidence profile →Public batch reports. Access is public, but authenticity and custody are not established.
Inspect transparency record →This difference compares list prices only. It does not assign value to a report or include shipping.
Calculate landed cost →How to read it: The Purgo Labs row is both the lowest confirmed in-stock list price and the lowest row with a public document route. Document visibility is not product verification.
Filter NAD+ vendors by stock, price, and public documents →Rank rule. Price rank is availability-aware and stays fixed when you search or re-sort this view. Affiliate status never enters the calculation.
Compare two lowest in-stock rowsChecked July 28, 2026 at 4:47 PM UTC. Confirmed means the public source matched the published price and returned a reliable current availability signal. No row needs manual review. This does not verify vial contents or product quality.
Open source-check ledger| Price rank / supplier | 1000 mg price | Price / mg | Public evidence | Shipping claim | Open listing |
|---|---|---|---|---|---|
01Purgo LabsLowest in-stock list priceIn stock | $69.99Source confirmed | $0.07 | Public batch reportsAccess: Public link · Seller claim · Jul 23, 2026 | Live UPS rate; free UPS 3 Day Select over $250 | |
02Prime PeptidesPublic reports displayedIn stock | $125.00Source confirmed | $0.13 | Reports displayedAccess: Public link · Seller claim · Jul 23, 2026 | $9.95 US; free over $150 | |
03Pepta LabsFree shipping claimedIn stock | $129.79Source confirmed | $0.13 | COA on requestAccess: On request · Seller claim · Jul 23, 2026 | Free US shipping claimed | |
04AminoCore ResearchPrice confirmed; stock not statedStatus not stated | $89.00Source confirmed | $0.09 | COA includedAccess: Included with order · Seller claim · Jul 23, 2026 | Free shipping claimed |
1 In-stock headline prices exclude unavailable listings, coupons, and checkout-only discounts.
2 A seller COA or report is labeled as a claim unless Peptide Local commissioned the sample and controlled custody.
How we read a certificate of analysis →How to verify the seller and access route →Start with how the document can be reached, then match it to this exact NAD+ 1000 mg row. Access is useful evidence, but it does not prove authenticity, custody, vial contents, sterility, or suitability.
The 1000 mg variation was in stock and linked public batch reports dated July 16 and June 7, 2026. Peptide Local did not authenticate custody or independently test the material.
Seller lists a certificate with the order and at least 99% HPLC purity. Peptide Local recorded the public claim without independently sampling the material.
Seller states third-party HPLC purity and ESI-MS identity testing with a batch certificate available on request. Peptide Local did not sample the vial.
Seller displays public testing reports from the product page. Peptide Local verified the document route, not chain of custody or the material in the vial.
The free checker keeps compound identity, lot matching, dates, laboratory attribution, report verification, custody, purity, identity testing, instrument output, and quantity separate.
These canonical matchups open directly on the NAD+ 1000 mg board. Price, stock, document access, source freshness, and shipping stay separate.
Purgo Labs is $59.80 lower before shipping.
Purgo Labs is $55.01 lower before shipping.
Prime Peptides is $4.79 lower before shipping.
Purgo Labs is the only row marked in stock.
Pair selection prioritizes rows that are currently comparable, include the board low, or expose a meaningful document-access contrast. It is not a seller ranking.
The public list price moved from $117.99 in Peptide Local's 2026-07-17 snapshot to $129.79 after four matching source checks. That is a $11.80 increase, or 10.00%.
The listing was recorded as in stock at publication and displayed at price position 3 on the current exact-size board. Unavailable rows cannot set the current in-stock low. Price movement does not establish product identity, quality, safety, or market-wide inflation.
Open the complete NAD+ price history →Open the full peptide price change record →NAD+ is a dinucleotide coenzyme rather than a peptide. This board includes it because the four compared research catalogs sell the same labelled 1000 mg form, while keeping its chemical category explicit.
Read the PubChem compound record ↗Price, chemical identity, clinical evidence, approved-product status, and local supply are different questions. This map shows which source answers each one and leaves unresolved fields visible.
Evidence routes checked through Jul 23, 2026NAD+ is a dinucleotide coenzyme, not a peptide. Peptide Local includes it because it appears in the same research catalogs and is often searched alongside peptides. A seller-labelled NAD+ product, infusion claim, capsule, powder, or local price does not establish identity, strength, quality, approval, clinical benefit, lawful supply, or seller authority in the selected destination.
Read the PubChem compound recordNational Library of Medicine, PubChem↗The price board can compare current list price, nominal size, availability, shipping language, and seller document access. It cannot establish identity, quantity, purity, sterility, legality, or fitness for use.
Inspect every price and source row3 currently confirmed in stock↓NAD+ is outside Peptide Local's current 13-program trial-count snapshot. That means no local count is published here, not that the count is zero. Search the live registry, then inspect the intervention, status, population, and posted results for each record.
Search NAD+ on ClinicalTrials.govLive official registry route, not a cached result count↗The global index joins this identity to official product and seller or supply routes in 22 content languages. Only 0 countries currently have a separate compound-specific status finding in this dataset.
Open the complete worldwide mapIdentity, product, seller, and supply checks stay separate↗The routes below are still useful, but they connect the identity to general official records. Missing compound-specific evidence is not a legal or availability conclusion.
No compound-specific United States finding is attached to this snapshot. The exact guide connects NAD+ to official product and seller or supply checks. That absence is not evidence of approval, prohibition, legality, availability, or seller authority.
No compound-specific Canada finding is attached to this snapshot. The exact guide connects NAD+ to official product and seller or supply checks. That absence is not evidence of approval, prohibition, legality, availability, or seller authority.
No compound-specific France finding is attached to this snapshot. The exact guide connects NAD+ to official product and seller or supply checks. That absence is not evidence of approval, prohibition, legality, availability, or seller authority.
No compound-specific México finding is attached to this snapshot. The exact guide connects NAD+ to official product and seller or supply checks. That absence is not evidence of approval, prohibition, legality, availability, or seller authority.
No compound-specific Australia finding is attached to this snapshot. The exact guide connects NAD+ to official product and seller or supply checks. That absence is not evidence of approval, prohibition, legality, availability, or seller authority.
It can show the visible list price, normalized unit cost, availability label, delivery claim, document language, destination market, and date checked.
A seller page or uploaded certificate does not replace independent sampling, chain-of-custody evidence, regulatory authorization, or professional judgment.
Current exact-size answers for price, document access, shipping, and source checks. No seller is converted into a product-quality or safety recommendation.
As of Jul 23, 2026, the lowest confirmed in-stock public list price in Peptide Local's exact-size US research-market sample is $69.99 from Purgo Labs. Shipping, tax, coupons, subscriptions, bundles, and checkout-only fees are not included.
2 confirmed in-stock rows link to a public seller document route: Purgo Labs, Prime Peptides. The lowest of those rows is Purgo Labs at $69.99. Public access does not authenticate a report, establish custody, or prove the contents of a supplied vial.
No. The board compares public single-unit list prices for the same 1000 mg nominal size. The current lowest row states: Live UPS rate; free UPS 3 Day Select over $250. Use the landed-cost calculator before treating the list-price order as the final order cost.
Confirm the exact identity and nominal size, current availability, landed cost, seller identity, destination-market rules, document route, lot or batch matching, analytical method, and source date. A seller-labelled research listing is not an approved medicine and public price or document access does not establish identity, purity, quantity, sterility, safety, legality, or fitness for human use.
Start by matching the exact NAD+ identity and 1000 mg listing to a current lot or batch identifier. Then check analysis date, named laboratory, report verification route, sample custody, separate purity and identity methods, instrument output, and any measured quantity result. Peptide Local's free ten-field checker can organize those questions, but document completeness does not prove authenticity or the contents of a supplied vial.
These guides explain local verification and access routes. They do not relabel this US research-price board as local inventory or medical availability.